Axel Ducret
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Clinical MAPPs: a personalized healthcare-driven assay for the direct identification of potential T cell epitopes in patients.
Journal: Frontiers in immunology
Published: May 12, 2026
Dendritic cell maturation assay for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform.
Journal: Frontiers in immunology
Published: September 15, 2025
MAPPs assays for non-clinical immunogenicity risk assessment: best practices recommended by the European immunogenicity platform.
Journal: Frontiers in immunology
Published: August 21, 2025
Elucidation of B-cell specific drug immunogenicity liabilities via a novel ex vivo assay.
Journal: Frontiers in immunology
Published: March 07, 2025
Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicity.
Journal: Frontiers in immunology
Published: April 15, 2024
Development and characterization of dendritic cell internalization and activation assays contributing to the immunogenicity risk evaluation of biotherapeutics.
Journal: Frontiers in immunology
Published: April 15, 2024
Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties.
Journal: Bioconjugate chemistry
Published: November 02, 2023
Tissue Mass Spectrometry: How Solid Is Our Future?
Journal: Clinical chemistry
Published: April 01, 2023
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics.
Journal: Pharmaceutics
Published: October 31, 2022
Last Updated: 09/26/2026